NEW YORK, May 5, 2014 /PRNewswire/ -- Medscape, the leading source of clinical news, health information, point-of-care tools and medical education for healthcare professionals throughout the world, and DXY.cn, the largest online community for healthcare professionals in China, today announced an exclusive collaboration to reach and educate physicians in China. The collaboration between Medscape and DXY will enable Medscape to distribute independent, educational programs to physicians and healthcare professionals in China through the popular DXY.cn site. The collaboration will bring timely and valuable clinical information to physicians throughout China who are looking to improve their knowledge and skills in rapidly changing areas of medicine. "Offering Medscape's education resources in China will enable us to capitalize on the opportunities in this growing market and provide physicians with high-quality medical education programming," said Jeremy Schneider, Managing Director, WebMD Global. "Combining Medscape's reach to over 1.3 million actively engaged physicians outside the U.S. with DXY's reach to Chinese physicians will further expand the international physician audience for Medscape's medical educational programming." The Medscape educational programs will be available to more than 1.8 million physicians in China. "This collaboration combines Medscape's global reputation for trusted medical content and DXY's expertise and reach to the large Chinese physician market to offer physicians in China high-quality, localized education resources," said Tiantian Li, Chairman and President, DXY. About WebMDWebMD Health Corp. (NASDAQ: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through our public and private online portals, mobile platforms and health-focused publications. The WebMD Health Network includes WebMD Health, Medscape, MedicineNet, eMedicineHealth, RxList, theheart.org, Medscape Education and other owned WebMD sites.